Behavioural Sciences Unit, Kids Cancer Centre, Sydney Children's Hospital, Randwick, New South Wales, Australia.
School of Women's and Children's Health, UNSW Sydney, Kensington, New South Wales, Australia.
Psychooncology. 2019 Jul;28(7):1520-1529. doi: 10.1002/pon.5109. Epub 2019 Jun 11.
Families of a child with cancer can find the decision to enrol in a clinical trial challenging and often misunderstand key concepts that underpin trials. We pilot tested "Delta," an online and booklet decision aid for parents with a child with cancer, and adolescents with cancer, deciding whether or not to enrol in a clinical trial.
We developed Delta in accordance with the International Patient Decision Aid Standards. We conducted a pre-post pilot with parents with a child, and adolescents, who had enrolled in a paediatric phase III clinical trial for newly diagnosed acute lymphoblastic leukaemia. Parents (n = 37) and adolescents (n = 3) completed a questionnaire before and after using Delta (either the website or booklet, based on their preference).
Twenty-three parents (62.2%) and three adolescents (100%) reviewed the Delta website. Parents rated Delta as highly acceptable in regard to being clearly presented, informative, easy to read, useful, visually appealing, and easy to use. All participants reported that they would recommend Delta to others and that it would have been useful when making their decision. Parents' subjective (M 10.8, SD = 15.69, P < .001) and objective (OR = 2.25, 95% CI, 1.66-3.04; P < .001) clinical trial knowledge increased significantly after reviewing Delta.
To our knowledge, Delta is the first reported decision aid, available online and as a booklet, for parents and adolescents deciding whether or not to enrol in a paediatric oncology clinical trial. Our study suggests that Delta is acceptable, feasible, and potentially useful.
癌症患儿的家属在决定是否参加临床试验时可能会感到困难,并且常常对支持试验的关键概念存在误解。我们对“Delta”进行了试点测试,这是一种针对癌症患儿及其父母的在线和手册式决策辅助工具,用于决定是否参加临床试验。
我们按照国际患者决策辅助标准开发了“Delta”。我们对参加新诊断急性淋巴细胞白血病儿科 III 期临床试验的患儿父母和青少年进行了一项预-后试点研究。父母(n=37)和青少年(n=3)在使用“Delta”前后(根据他们的偏好,分别为网站或手册)填写了一份问卷。
23 位父母(62.2%)和 3 位青少年(100%)查看了“Delta”网站。父母认为“Delta”在呈现方式、信息丰富度、易读性、实用性、视觉吸引力和易用性方面都非常高。所有参与者均表示愿意向他人推荐“Delta”,并认为在做出决策时会很有用。父母的主观(M 10.8,SD=15.69,P<.001)和客观(OR=2.25,95%CI,1.66-3.04;P<.001)临床试验知识在使用“Delta”后显著增加。
据我们所知,“Delta”是首个可供父母和青少年在线和手册查阅的决策辅助工具,用于决定是否参加儿科肿瘤临床试验。我们的研究表明,“Delta”是可接受的、可行的,并且具有潜在的用处。